Archimedes Tech SPAC Partners II Co. Ordinary Shares (ATII)

FairStock Score: 42/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Archimedes Tech SPAC Partners II as a blank check, not an operating business. It has no significant operations and intends to merge with a technology company. That means there is no revenue, no competitive moat, and no durable earnings stream to analyze. The filed figures show fiscal year 2025 net income of $8.0 million, fiscal Q1 2026 net income of $1.7 million, fiscal Q3 2025 net income of $2.4 million, and fiscal Q2 2025 net income of $2.4 million. Then fiscal Q2 2026, the quarter ended 2026-06-30, produced a net loss of $136.8 million. That swing is a warning: reported results are volatile and likely reflect accounting or non-operating items rather than a business compounding value. FairStock's calculations at the 2026-10-13 close of $10.71 show a negative P/E of -2.43, ROCE of -0.41%, trailing free cash flow of -$1.3M, FCF yield of -0.4%, Piotroski F-Score of 1/9, and Altman Z-Score of -0.22. Those are not the marks of a fortress balance sheet or an earning machine. Market cap is $316.9M, and the 52-week range is $10.31-$11.40, so the price is stable but not statistically cheap against the little we know. The FairStock Score is 42/100, and its Lynch category is none because only one year of filed results exists. Without a target, terms, or post-merger financials, I cannot judge growth. The margin of safety depends on cash held and deal structure, not on current operations. Until a merger is announced and numbers can be underwritten, this is speculation around a shell, not a Graham-style bargain.

In plain English: Archimedes Tech SPAC Partners II is a blank-check company with no real business operations yet; it plans to merge with a technology company. Its reported profits are small and uneven, including a very large loss in the quarter ended June 30, 2026, so the business itself cannot be called strong or weak. At $10.71, the shares trade near the middle of their 52-week range of $10.31 to $11.40, and with no revenue or clear target, the price looks neither clearly cheap nor clearly expensive based on the limited facts.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer